Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

High-unbound mycophenolic acid concentrations in an infant on peritoneal dialysis following hematopoietic cell transplant

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jacobson P, Long J, Rogosheske J, Brunstein C, Weisdorf D . High unbound mycophenolic acid concentrations in a hematopoietic cell transplantation patient with sepsis and renal and hepatic dysfunction. Biol Blood Marrow Transplant 2005; 11: 977–978.

    Article  Google Scholar 

  2. Weber LT, Shipkova M, Lamersdorf T, Niedmann PD, Wiesel M, Mandelbaum A et al. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German study group on mycophenolate mofetil therapy in pediatric renal transplant recipients. J Am Soc Nephrol 1998; 9: 1511–1520.

    CAS  PubMed  Google Scholar 

  3. Weber LT, Lamersdorf T, Shipkova M, Niedmann PD, Wiesel M, Zimmerhackl LB et al. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German study group on mycophenolate mofetil therapy in pediatric renal transplant recipients. Ther Drug Monit 1999; 21: 498–506.

    Article  CAS  Google Scholar 

  4. Shaw LM, Mick R, Nowak I, Korecka M, Brayman KL . Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function. J Clin Pharmacol 1998; 38: 268–275.

    Article  CAS  Google Scholar 

  5. MacPhee IA, Spreafico S, Bewick M, Davis C, Eastwood JB, Johnston A et al. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure. Kidney Int 2000; 57: 1164–1168.

    Article  CAS  Google Scholar 

  6. Anonymous. CellCept, Package Insert. Roche Laboratories: Nutley, NJ, USA, 2004.

  7. Mudge DW, Atcheson BA, Taylor PJ, Pillans PI, Johnson DW . Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient. Ther Drug Monit 2004; 26: 453–455.

    Article  Google Scholar 

  8. Kaplan B, Gruber SA, Nallamathou R, Katz SM, Shaw LM . Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure. Transplantation 1998; 65: 1127–1129.

    Article  CAS  Google Scholar 

  9. Weber LT, Shipkova M, Armstrong VW, Wagner N, Schutz E, Mehls O et al. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J Am Soc Nephrol 2002; 13: 759–768.

    Article  Google Scholar 

  10. Atcheson BA, Taylor PJ, Kirkpatrick CM, Duffull SB, Mudge DW, Pillans PI et al. Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Ther Drug Monit 2004; 26: 284–286.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P A Jacobson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobson, P., Rydhom, N., Huang, J. et al. High-unbound mycophenolic acid concentrations in an infant on peritoneal dialysis following hematopoietic cell transplant. Bone Marrow Transplant 40, 911–912 (2007). https://doi.org/10.1038/sj.bmt.1705837

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705837

This article is cited by

Search

Quick links